LRP 4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients

JS Tzartos, P Zisimopoulou, M Rentzos… - Annals of clinical …, 2014 - Wiley Online Library
Objective Amyotrophic lateral sclerosis (ALS) and myasthenia gravis (MG) are caused,
respectively, by motor neuron degeneration and neuromuscular junction (NMJ) dysfunction …

LRP 4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients

JS Tzartos, P Zisimopoulou, M Rentzos… - Annals of Clinical …, 2014 - search.proquest.com
Objective Amyotrophic lateral sclerosis (ALS) and myasthenia gravis (MG) are caused,
respectively, by motor neuron degeneration and neuromuscular junction (NMJ) dysfunction …

[PDF][PDF] LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients

JS Tzartos, P Zisimopoulou, M Rentzos, N Karandreas… - Neurology, 2014 - academia.edu
Objective: Amyotrophic lateral sclerosis (ALS) and myasthenia gravis (MG) are caused,
respectively, by motor neuron degeneration and neuromuscular junction (NMJ) dysfunction …

[PDF][PDF] LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients

JS Tzartos, P Zisimopoulou, M Rentzos… - …, 2014 - scienceopen.com
Objective: Amyotrophic lateral sclerosis (ALS) and myasthenia gravis (MG) are caused,
respectively, by motor neuron degeneration and neuromuscular junction (NMJ) dysfunction …

LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients

JS Tzartos, P Zisimopoulou, M Rentzos… - ANNALS OF CLINICAL …, 2014 - air.unimi.it
Objective: Amyotrophic lateral sclerosis (ALS) and myasthenia gravis (MG) are caused,
respectively, by motor neuron degeneration and neuromuscular junction (NMJ) dysfunction …

LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients

JS Tzartos, P Zisimopoulou… - Annals of clinical …, 2014 - pubmed.ncbi.nlm.nih.gov
Objective Amyotrophic lateral sclerosis (ALS) and myasthenia gravis (MG) are caused,
respectively, by motor neuron degeneration and neuromuscular junction (NMJ) dysfunction …

[HTML][HTML] LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients

JS Tzartos, P Zisimopoulou, M Rentzos… - Annals of Clinical and …, 2014 - ncbi.nlm.nih.gov
Objective Amyotrophic lateral sclerosis (ALS) and myasthenia gravis (MG) are caused,
respectively, by motor neuron degeneration and neuromuscular junction (NMJ) dysfunction …

[PDF][PDF] LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients

JS Tzartos, P Zisimopoulou, M Rentzos, N Karandreas… - Neurology, 2014 - Citeseer
Objective: Amyotrophic lateral sclerosis (ALS) and myasthenia gravis (MG) are caused,
respectively, by motor neuron degeneration and neuromuscular junction (NMJ) dysfunction …

[引用][C] LRP 4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients

JS Tzartos, P Zisimopoulou, M Rentzos… - Annals of Clinical and …, 2013 - cir.nii.ac.jp
<scp>LRP</scp> 4 antibodies in serum and <scp>CSF</scp> from amyotrophic lateral
sclerosis patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients.

JS Tzartos, P Zisimopoulou, M Rentzos… - Annals of Clinical and …, 2013 - europepmc.org
Objective Amyotrophic lateral sclerosis (ALS) and myasthenia gravis (MG) are caused,
respectively, by motor neuron degeneration and neuromuscular junction (NMJ) dysfunction …